April 1st 2025
William Wainwright, business development manager at Iwata Label USA, discusses the practical security benefits of functional labels at INTERPHEX 2025.
The evolution of therapeutic modalities drives the adoption of single-use technologies.
Handling HPAPIs: Do Your CMOs Have the Right Stuff?
August 1st 2015Ignoring a contract partner’s ability to handle highly potent APIs (HPAPIs) safely may have serious consequences. Drug owners and contract service providers alike must understand the complexities and liabilities involved in working with HPAPIs.